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Abstract: Methyl groups are important for numerous cellular functions such as DNA 
methylation, phosphatidylcholine synthesis, and protein synthesis. The methyl group can 
directly be delivered by dietary methyl donors, including methionine, folate, betaine, and 
choline. The liver and the muscles appear to be the major organs for methyl  
group metabolism. Choline can be synthesized from phosphatidylcholine via the  
cytidine-diphosphate (CDP) pathway. Low dietary choline loweres methionine formation 
and causes a marked increase in S-adenosylmethionine utilization in the liver. The link 
between choline, betaine, and energy metabolism in humans indicates novel functions for 
these nutrients. This function appears to goes beyond the role of the nutrients in gene 
methylation and epigenetic control. Studies that simulated methyl-deficient diets reported 
disturbances in energy metabolism and protein synthesis in the liver, fatty liver, or muscle 
disorders. Changes in plasma concentrations of total homocysteine (tHcy) reflect one 
aspect of the metabolic consequences of methyl group deficiency or nutrient 
supplementations. Folic acid supplementation spares betaine as a methyl donor. Betaine is 
a significant determinant of plasma tHcy, particularly in case of folate deficiency, 
methionine load, or alcohol consumption. Betaine supplementation has a lowering effect 
on post-methionine load tHcy. Hypomethylation and tHcy elevation can be attenuated 
when choline or betaine is available. 
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The transmethylation cycle is strongly regulated by feedback mechanisms. For example, SAM 
activates cystathionine beta synthase to enhance the conversion of homocysteine into cysteine, the 
precursor of glutathione and taurine. In contrast, SAM inhibits BHMT, thus reducing the utilization of 
betaine as a methyl donor. Moreover, SAM inhibits methylenetetrahydrofolate reductase (MTHFR), 
thereby reducing the availability of 5-MTHF as a methyl donor. The product of betaine demethylation, 
dimethylglycine (DMG), inhibits BHMT and controls methyl group transfer. Methionine load activates 
the transsulfuration pathway, whereas the remethylation pathway via methionine synthase is active 
under fasting conditions. 
The process of methylogenesis depends on several nutrients such as folate, methionine, vitamins 
B12, B6, and B2, betaine, and choline. The methylation potential (SAM/SAH ratio) is rather resistant 
to fluctuations in independent nutrients [2]. A study on rural African women showed that seasonal 
variations were ameliorated by the intake of the dietary methyl donors such as folate, betaine, and 
vitamins B6 and B12 [2]. Moreover, there appeared to be a seasonal switch between the folate and 
betaine pathways as sources of methyl groups in this study on African women [2]. 
3. Methyl Donor: Folate 
Folate (vitamin B9) is a member of the B-vitamin group that is required for crucial cell processes. 
Green leafy plants are rich sources of folate in human diet. The recommended daily intake of folate in 
adults is 400 µg/day. Formyltetrahydrofolate and methenyltetrahydrofolate are utilized in the synthesis 
of purine and pyrimidine, respectively. Moreover, 5-MTHF plays a key role as a methyl donor. Three 
enzymes are required to produce methyl groups via the folate cycle: serine hydroxymethyl transferase 
(SHMT), MTHFR, and methionine synthase. Methionine synthase, a vitamin B12-dependent enzyme, 
facilitates the last step of methyl group transfer from 5-MTHF to homocysteine to form methionine. 
Folate deficiency causes anemia and depression, and increases the risk of pregnancy complications and 
birth defects [3,4]. A recent meta-analysis suggested an association between the C677T polymorphism 
in the MTHFR gene and neural tube defects, independent of folate status [5]. Inactivation of  
10-formyltetrahydrofolate synthetase lowered purine synthesis and slowed cell proliferation [6]. 
Maternal Mthfd1 disruption impairs fetal growth but was not associated with birth defects [7]. 
Approximately 30%–70% of neural tube defects can be prevented by taking folic acid 
supplementations before conception, though the mechanisms of the preventive role of folate have not 
been thoroughly studied. Folate deficiency causes several metabolic changes in the cell, including 
hyperhomocysteinemia, low SAM levels, and DNA hypomethylation [8,9]. 
4. Methyl Donors: Betaine and Choline 
Betaine is the methyl donor in the BHMT pathway and is a methylamine as it contains three 
chemically reactive methyl groups linked to a nitrogen atom. Wheat bran, wheat germ, spinach, and 
beets are rich sources of betaine in the human diet. Betaine intake varies between populations (range: 
100–400 mg/day) [10,11]. Much lower intakes (mean, 33 mg/day) have been reported in one recent 
study on rural African women [2], suggesting that the regulation of the methylation cycle may differ 
according to lifestyle and environmental factors. Moreover, differences in intake data between 
populations may be related to under- or over-estimation of the food contents of betaine and choline. 
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In addition to dietary sources, betaine can be produced through the irreversible oxidation of choline 
via choline dehydrogenase and betaine aldehyde dehydrogenase. Betaine is converted into DMG as it 
donates a methyl group to homocysteine. This pathway is mediated by BHMT, an enzyme induced by 
betaine [12] and inhibited by DMG or SAM [13]. A small amount of DMG is eliminated in  
the urine, and most DMG is converted via DMG-dehydrogenase into sarcosine and glycine.  
DMG-dehydrogenase is a mitochondrial flavoprotein and folate-binding protein. It transfers one-carbon 
unit to tetrahydrofolate to produce 5,10-methylenetetrahydrofolate. The non-essential amino acid 
glycine enters the folate cycle to produce 5,10-methylenetetrahydrofolate or is used to synthesize bile 
salts, glutathione, and proteins such as collagen. Alternatively, glycine is used for creatine synthesis 
via guanidinoacetate in a SAM-dependent pathway [14]. The flow of methyl groups via the BHMT 
pathway is not dependent on folate or vitamin B12, but there are several cross-talk mechanisms 
between the BHMT and the folate pathways. Choline has been shown to indirectly support 
homocysteine methylation [15]. One study of postmenopausal women showed that choline 
supplementation increased plasma betaine levels and slightly lowered plasma levels of total 
homocysteine (tHcy) after six weeks (median change, −0.9 vs. +0.6 μmol/L in the placebo group:  
p = 0.058) and 12 weeks [15]. Sex- and age-related differences in choline requirements and blood 
levels have been reported. Women have lower plasma concentrations of betaine and choline than men, 
as well as younger subjects, showed lower betaine concentrations than older subjects [16]. 
Red meat, poultry, milk, egg, and fish are rich sources of choline [10]. The estimated recommended 
intake for choline for adults is 550 mg/day for men, 425 mg/day for women, 450 mg/day for pregnant 
women, and 550 mg/day for lactating women [17]. The upper tolerable limit for adults is 3.5 g/day. In 
addition to the diet, a main source of choline is de novo synthesis from phosphatidylcholine via the 
CDP-pathway. Phosphatidylcholine can be formed either from choline or from phosphatidylethanolamine 
via the phosphatidylethanolamine methyltransferase (PEMT) pathway. Choline generation via PEMT 
consumes a significant amount of SAM (3 mole SAM to produce 1 mole choline) and produces 
homocysteine. Accordingly, PEMT knockout mice show lower plasma concentrations of tHcy [18]. In 
contrast, mice deficient in liver CTP:phosphocholine cytidylyltransferase have high tHcy and low 
phosphatidylcholine because of low production from choline [19]. SAM concentrations are maintained 
by stimulating the BHMT pathway [19]. 
Available evidence suggests that folate deficiency can be partly attenuated when choline is 
available and vice versa. For example, choline and phosphatidylcholine were depleted in the livers of 
rats fed a folate-deficient diet [20]. In contrast, consumption of a choline-deficient diet decreased 
hepatic folate stores [21]. A choline-deficient diet lowered methionine formation in animal livers by 
20%–25% [22], probably because less choline was available for conversion into betaine. However, the 
effects of choline deficiency on reducing liver SAM (by 60%) and increasing liver SAH (by 50%) 
were impressive [22]. Therefore, the effect of choline deficiency on lowering SAM is probably not 
solely mediated by lowering methionine. A choline-deficient diet may increase SAM utilization in the 
liver, to convert phosphatidylethanolamine into phosphatidylcholine via PEMT. 
The liver and the muscles are the major sites of choline metabolism. Choline deficiency caused 
fatty liver and muscle damage in humans and increased hepatic carcinogenesis in rodents exposed to 
alcohol [23]. 
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5. Metabolic Burden of a Methyl-Deficient Diet 
Studies simulating methyl-deficient diets have reported disorders in protein synthesis in the liver 
and fatty liver as well as muscle disturbances [24–26]. Betaine [27–30], choline, or folate [31] were 
able to reverse alcohol-related or non-alcohol related liver disturbances, probably via epigenetic 
regulation [32] or lipid-related mechanisms. The quantitative participation of each of the methyl 
donors in the daily net flow of methyl groups has not been thoroughly examined [33,34]. Large 
fluctuations in plasma concentrations of folate and betaine were ameliorated and not translated to large 
fluctuations in the plasma SAM/SAH ratio [2]. However, the plasma SAM/SAH ratio did not show 
significant changes, and it is currently not known whether this ratio reflects the methylation potential 
in all organs. 
Betaine is stored in the cell and hence represents a ready-to-use methyl group source. Animal 
studies have shown that plasma betaine is a poor predictor of tissue betaine content [35]. DMG 
concentrations in plasma may be a good indicator of betaine utilized as a methyl donor [2]. For 
example, plasma betaine was increased in only 36% of folate-deficient patients and in 12% of  
folate-deficient patients who had severe alcoholic liver disease [36]. Plasma DMG was increased in 
74% of the folate-deficient patients [36], suggesting that plasma DMG rather than betaine may be a 
good marker for betaine utilization as a methyl donor [36]. 
Despite the questionable importance of low and high plasma betaine [37], plasma betaine is a 
significant determinant of plasma tHcy concentration. A recent study in a large sample of pregnant 
women showed that women with low plasma folate at 24–27 gestational weeks (<11.4 nmol/L) had 
lower plasma betaine and higher DMG and tHcy until the end of pregnancy compared to women with 
plasma folate above 11.4 nmol/L [38]. Plasma betaine is a negative predictor of increased plasma tHcy 
after methionine load in subjects with low folate [39]. Moreover, a low methionine diet slightly enhanced 
the BHMT pathway rather than the transsulfuration pathway [40]. Similarly, in cases of folate 
deficiency, the BHMT pathway appears to be a feasible method for re-methylating homocysteine after a 
methionine load [39,41]. In contrast, folate supplementation causes a dose-dependent increase in plasma  
betaine [42], suggesting that betaine is being utilized to a lower extent. In non-supplemented individuals, 
the concentrations of folate and betaine showed no correlation, and plasma folate was not a significant 
predictor of plasma betaine [42]. Another study examining healthy individuals (mean age, 36 years) who 
were not receiving supplements revealed a direct relationship between plasma betaine and choline and 
that of serum folate, but no relationship with plasma tHcy [43]. Plasma SAM concentrations were 
positively correlated with plasma levels of choline and DMG, but not with that of betaine [43]. 
Changes in tHcy concentrations reflect only one side of the metabolic burden of methyl group 
deficiency or nutrient supplementation. Folate [16], betaine [16,33,44], and choline [45] are significant 
determinants of the fasting plasma concentrations of tHcy. Betaine and choline intake were inversely 
related to fasting and post-methionine load tHcy concentrations [46]. This inverse correlation was no 
longer present in populations ingesting foods fortified with folic acid [46]. As folic acid lowers plasma 
tHcy, betaine is probably more effective as a methyl donor and as a tHcy-lowering nutrient in 
populations not on fortification programs compared to those on such programs [46]. One study showed 
that plasma concentrations of tHcy and betaine are inversely correlated in healthy men and  
women [42]. Supplementing folic acid 400–800 µg/day for 12 weeks caused a 15% increase in plasma 
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betaine levels, but the inverse correlation between tHcy and betaine remained significant after 
supplementation [42]. In general betaine seems to be less involved in tHcy methylation in people who 
received folic acid supplementation than in those who did not receive folate supplementation. In 
agreement with these results, in subjects with low serum folate, concentrations of fasting or  
post-methionine load tHcy and that of betaine showed a pronounced inverse association [16]. Plasma 
folate is a more important determinant of plasma tHcy than plasma betaine [16]. Furthermore, acute 
supplementation of a small dose of 550 mg betaine slightly lowered circulating tHcy and increased 
DMG, with minimal levels of betaine appearing in the urine, suggesting that betaine was metabolized 
and partly stored in tissues [42]. Only a small amount is excreted in the urine, even when 
supplementation is continued [42]. Acute supplementation of betaine (550 mg) had a stronger lowering 
effect on post-methionine load tHcy concentrations in one study on healthy men [42]. In a further 
study that included patients with renal failure, a large dose of betaine (4 g/day) for three months caused 
no additional lowering of tHcy when given with 5 mg folic acid and 50 mg B6 compared to 5 mg folic 
acid plus 50 mg B6 without betaine [41]. However, betaine increased plasma and urine betaine and 
DMG in this study [41], suggesting that at least some of the betaine was metabolized to DMG. 
Phosphatidylcholine supplementation for two weeks in healthy men from a population without 
mandatory fortification with folic acid lowered mean plasma tHcy by 18% [−3.0 (−3.9, −2.1) µmol/L] 
and mean post-methionine load tHcy by 29% [−9.2 (−11.3, −7.2) µmol/L] compared to the  
placebo [47]. The intake of glycerophosphocholine (mainly obtained from milk) was negatively related 
to plasma tHcy in women with low intakes of folate (<400 µg/day) (mean tHcy 12.0 vs. 10.2 µmol/L: 
−15%) [11]. Alcohol consumption (≥15 g/day) was also a strong predictor of the inverse association 
between choline and tHcy in women with low folate intake [11]. Alcohol is known to inhibit 
methionine synthase activity in the liver, thus increasing plasma tHcy, lowering liver SAM, and 
causing fatty liver [48]. Therefore, the BHMT pathway becomes more important as a source of SAM 
and determinant of tHcy in alcoholism [48]. 
The effect of folate in preventing tHcy elevation was recently tested in BHMT deleted mice  
(Bhmt−/−) [49]. Bhmt−/− mice showed approximately 10-fold higher plasma tHcy, heavier liver (fatty 
liver), lower liver SAM, and higher liver SAH than Bhmt+/+ mice [49]. tHcy elevation was not corrected 
after folic acid supplementation. However, folic acid supplemented Bhmt−/− mice were able to produce 
more hepatic SAM compared to Bhmt−/− mice fed a folate-deficient diet or those on a control diet [49]. 
The results suggest that folate enhanced SAM production via the methionine synthase pathway, but was 
not able to remove tHcy in this mouse model. The BHMT pathway appears to substantially participate in 
tHcy metabolism in mice [50]. At least in this mouse model, folic acid supplementation did not 
counterbalance the metabolic burden caused by disrupting the BHMT enzyme. 
Taken together, betaine and choline support the role of folate in lowering fasting tHcy. The effect of 
betaine on lowering post-methionine load tHcy is stronger than its effect on fasting tHcy [41]. The 
tHcy-lowering effect of betaine is higher in individuals not receiving folic acid. The effect of betaine 
on plasma tHcy appears to be more dependent on plasma folate than on plasma betaine [51]. In  
folate-deficient patients, plasma betaine and methionine concentrations were maintained and DMG 
was increased, suggesting that betaine acted as a methyl donor to produce methionine and DMG [51]. 
Plasma betaine does not reflect tissue betaine, but may reflect transient changes in the labile methyl 
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group in case of higher requirements (pregnancy, liver damage), after methionine-load, or after folic 
acid supplementation. 
6. Metabolic Burden: Osmotic Stress and Energy Metabolism 
6.1. Osmotic Stress 
Betaine is a major osmolyte in the cell [52]; it regulates the cell volume and stabilizes proteins. It is 
stored at high amounts in the liver and the kidney. Betaine levels in skeletal muscles are similar to 
those in the plasma and brain [35]. Betaine prevents osmolytic stress when added to farmed fish upon 
transfer from low to high salinity. Moreover, in cells exposed to hyperosmotic conditions, choline 
uptake is enhanced in mitochondria in order to resist volume reduction and osmotic water loss. Choline 
is converted into betaine under these conditions [53]. 
6.2. Energy and Lipid Metabolism 
Hypomethylation is involved in energy metabolism disorders. Much on betaine effects can be 
learned from animal studies. Betaine has been an important component of animal nutrition for over  
50 years. A choline-rich diet is an additional source of betaine since choline is oxidized to betaine by 
the mitochondrial enzyme choline dehydrogenase [54] and betaine aldehyde dehydrogenase, which is 
expressed in the cytosol and mitochondria. 
Betaine was shown to be related to protein (muscular tissue) and fat metabolism [55]. Moreover, 
betaine has been discussed in animal nutrition for its role in saving methionine and choline [56,57]. 
The methionine-sparing effect of betaine makes methionine more available for protein synthesis, and 
the choline-sparing effect makes choline more available for lipid metabolism. The role of betaine in 
energy metabolism appears to be effective at low total energy intake. Betaine is useful as a partitioning 
agent under low amino acid and energy intake situations in animals [56,57]; thus, it has the potential to 
solve public health problems related to excess fat in meat products. 
Betaine is considered to be a lipotropic compound that can influence lipid metabolism in  
animals [58]. It improves energy metabolism probably by supporting the synthesis of carnitine, which 
is necessary for the transport of long-chain fatty acids to the mitochondria where they are  
oxidized [58]. Löest et al. found that betaine may decrease the demand for choline methyl groups, thus 
increasing choline availability for lipid metabolism [59]. This was supported by the findings of Yao 
and Vance [60] showing that betaine can correct very low density lipoprotein (VLDL) secretion from 
hepatocytes grown in a choline deficient medium. 
Human studies have demonstrated a relationship between low betaine and BMI. In one large 
population-based study, BMI was inversely related to betaine and directly related to choline [61]. The 
same was found for body fat and triglycerides [61]. In a further study, plasma betaine was lower in 
men with BMI ≥ 25 kg/m2 compared with men with BMI < 25 kg/m2 (median 37.3 vs. 40.1:  
p = 0.049), but plasma choline did not differ significantly [62]. In obese men, plasma betaine was 
inversely related to blood lipids and liver enzymes [62], suggesting that betaine (or choline) can 
ameliorate fatty liver and the components of metabolic syndrome. The distribution of choline between 
the methylation and phospholipid pathways appears to play a key role in energy metabolism since the 
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association of alanine aminotransferase (ALT is a liver enzyme) and low-density lipoprotein  
(LDL)-cholesterol showed a negative association with the betaine/choline ratio only in individuals 
with a polymorphism in PEMT (PEMT5465 GG) [62]. A genotype-phenotype-specific relationship 
between choline metabolites and metabolic stress has been suggested [62], but needs to be confirmed. 
A very high-methionine/low-folate diet caused hyperhomocysteinemia and accumulation of 
cholesterol and triacylglycerol in mouse liver but not in the plasma [63]. Plasma VLDL was increased, 
suggesting that the excretion of VLDL from the liver was not impaired [63]. Activation of both the 
unfolded protein response and sterol regulatory element-binding proteins has been suggested. In cases 
of higher plasma folate, choline is probably spared and utilized for phospholipid synthesis. This can 
explain results on the inverse association between plasma folate and plasma lipoproteins  
(LDL-cholesterol) [64], or the increased high-density lipoprotein (HDL)-cholesterol levels after folic  
acid supplementation [65]. 
A moderate high-fat diet (20% of total calories from fat) in mice caused a higher body weight, blood 
glucose, triglycerides, and insulin compared with a low-fat diet (9% of total calories from fat) [28]. 
Betaine supplementation was able to prevent and reverse fatty liver, lower serum ALT, and improve 
insulin resistance in mice fed a high-fat diet for up to eight months [28]. Betaine was also able to correct 
insulin signaling by activating insulin receptor substrate 1 (IRS1) by increasing tyrosine phosphorylation 
and other signaling mechanisms that regulate gluconeogenesis and glycogen synthesis [28]. 
The role of betaine and choline in energy metabolism appears to be beyond the effect on gene 
methylation and epigenetic control since folate is not known to show the same effect on energy 
metabolism, but rather on epigenetic events. 
7. Methyl Donor and Physiological and Disease Conditions 
Physiological changes in plasma folate and tHcy during pregnancy have been reported previously. 
Pregnancy-related changes in plasma betaine and choline have also been reported [38,66]. From 
gestational week eight onward, choline increased during pregnancy while betaine decreased. From  
20 gestational weeks onward, betaine was a stronger predictor of plasma tHcy than folate [66].  
Increased plasma choline during pregnancy [38] is probably related to enhanced endogenous synthesis, 
since PEMT enzyme is induced by estrogen. Decreased betaine during pregnancy is associated with 
increased DMG suggesting that a significant amount of methyl groups are afforded by the BHMT 
pathway at late gestation [38]. The role of the BHMT pathway in delivering methyl groups may be 
even more significant in pregnant women with low folate [38]. Folate [67] and choline have been 
related to cognitive development and brain function. In a recent report from the Hordaland Health 
Study on 2190 participants, better cognitive function was associated with higher choline and B12 or 
higher betaine and B12 [68]. 
Folate or choline deficiency has been related to several adverse health effects in humans. The 
association between folate deficiency and cancer is also well-documented [69]. The most important 
diseases associated with folate deficiency are neural tube defects. Choline deficiency or defects in 
choline metabolism have been also linked to fetal brain development and birth defects [70,71]. Defects 
in choline utilization cause early embryonic lethality and have severe effects on embryo survival or 
development [72]. Furthermore, severe heart defects were observed when a choline deficient diet  
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(1/8 of the recommended daily intake) was administered to mice, six weeks before conception [73]. 
Folate and choline can prevent disorders in brain development and function, at least in part by 
supplementing methyl groups. 
Both high and low plasma concentrations of betaine are linked to diseases [37]. Urinary betaine 
excretion is increased in approximately 20% of patients with type 2 diabetes [74]. Low levels of 
plasma betaine are associated with cardiovascular risk factors and probably cardiovascular risk [44]. 
Several mechanisms may explain the role of dietary methyl donors in human diseases. For example, 
hypo- or hyper methylation of DNA and disruption of DNA repair were reported in cancer patients and 
were related to methyl donors [75,76]. Disturbed methylation of key proteins in the brain plays a 
central role in the neurodegenerative process and enhances the pathology of amyloid beta and the tau 
protein [77]. Other mechanisms may be related to the toxic effects of hyperhomocysteinemia or 
oxidative stress. Osmotic stress caused by low intracellular betaine can affect protein stability and 
signaling pathways in the cell [28]. Disruption of the methylation pathway in the liver (by alcohol or 
choline deficiency) causes accumulation of lipids and fatty liver. Finally, mechanisms not related to 
methylation may be involved. For example, choline is used for synthesizing the neurotransmitter 
acetylcholine and the important membrane lipid, phosphatidylcholine. 
8. Conclusions 
Metabolism of folate, betaine, choline, and methionine are interrelated, and deficiency of one nutrient 
can be partly compensated for. Deficiency of dietary methyl donors can cause metabolic and functional 
disturbances. Metabolic changes in the cell are reflected by elevated tHcy levels, disturbed energy and 
lipid metabolism, and dysregulation of DNA methylation and protein synthesis. Folate supplements save 
betaine as a methyl donor, and betaine supplementation appears to have a lowering effect on  
post-methionine loading of tHcy. The association between fasting plasma tHcy and plasma betaine or 
choline appears to be equivocal; however, betaine or choline supplementation can lower plasma tHcy. 
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